|Mr. Anthony John Durkacz||Founder & Co-Chairman||N/A||N/A||1976|
|Dr. Raza Bokhari M.B.A., MBA||Exec. Co-Chairman & Interim CEO||N/A||N/A||1968|
|Mr. Zeeshan Saeed||Founder, Pres & Director||N/A||N/A||N/A|
|Mr. Donal Carroll||Interim Chief Financial Officer||N/A||N/A||N/A|
|Ms. Sandy Huard||Head of Investor Relation||N/A||N/A||N/A|
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of the indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. It has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products; and a collaborative research and development agreement with Solarvest BioEnergy Inc. to develop algae-based pharma-grade cannabinoids. FSD Pharma Inc. is headquartered in Cobourg, Canada.
FSD Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.